Brochure More information from

Transcription

1 Brochure More information from Stem Cells: Worldwide Markets for Transplantation and Cord Blood Banking (Projections for Stem Cell Use in Cancer, Alzheimer s, Diabetes, Arthritis and Other Diseases) Description: There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies. Stem cells also have value as a research tool, as their in vitro study would allow scientists to learn more about the function of various organs and the development of particular diseases; stem cells may also eventually permit drug developers to test emerging therapies on diseased cells. For market-watchers in the pharmaceutical industry, the question is what potential they have and where they could take the pharmaceutical market. New scientific developments and recent changes in the U.S. Federal government's policy towards stem cells have made this potential more relevant. Kalorama Information has tackled the question in Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development. Kalorama analyst Alison Sahoo has built models to determine the best, moderate and worst case scenarios for the three key markets for stem cells: Stem Cells in Drug Development Stem Cells in Cord Blood Banking The potential of stem cell therapeutics is provided, broken down by disease: Cardiovascular disease Lung disease Tooth disease Arthritis Wrinkles/aging skin Incontinence Osteoporosis Diabetes Cancer Bladder disease Infertility Orthopedics Alzheimer s disease Burns (severe) Lupus Parkinson s disease Liver failure Multiple sclerosis Critical limb ischemia Intestinal disease Sickle cell disease Multiple myeloma NH Lymphoma Leukemia The following trends are discussed in this report: Ethical Questions U.S. State and Federal Initiatives Research Funding Cord Blood Initiatives International Initiatives Stem Cell Patents Other Healthcare Regulations

2 All Kalorama reports advertise the single user price, which limits access to one user. We also feature department and global pricing for reports that will be utilized by more than one user at your company. Please ask your sales representative or select the correct license on our website. For Kalorama's take on the healthcare news of the week, based on our analysis of healthcare markets, follow Kalorama Information's Key Point Blog at Contents: CHAPTER ONE: EXECUTIVE SUMMARY Scope and Methodolgy Introduction Current Stem Cell Therapies Developmental Stem Cell Therapies Issues In Stem Cell Research Stem Cell Forecasts CHAPTER TWO: INTRODUCTION The Promise of Stem Cells In Medical Treatment Types of Stem Cells Embryonic Stem Cells Adult Stem Cells Cord Blood Stem Cells Stem Cell Harvesting Embryonic Stem Cells Therapeutic Cloning Unfertilized Eggs Adult Stem Cells Leukapheresis Peripheral Blood Cord Blood Stem Cells Transplantation Approaches Autologous Transplantation Allogenic Transplantation Transplantation Procedures Cancerous Stem Cells Other Harmful Stem Cells Stem Cells in Drug Development Stem Cells Targeting Drugs Stem Cell Generated Organs CHAPTER THREE: CURRENT STEM CELL THERAPIES Cancer Leukemia Gene Therapy Multiple Myeloma Non-Hodgkin s Lymphoma Non Cancerous Diseases Aplastic anemia Immunodeficiency Lupus Sickle Cell Disease Other Conditions CHAPTER FOUR: DEVELOPMENTAL STEM CELL THERAPIES Alzheimer s Disease Arthritis Bladder Disease Burns Cancer Cardiovascular Conditions Critical Limb Ischemia Diabestes Esophagal Disease

3 Incontinence Infertility Intestinal Disease Liver Failure Lung Disease Multiple Sclerosis Orthopedics Osteoporosis Parkinson s Disease Sickle Cell Disease Tooth Disease Wrinkles/Aging Skin CHAPTER FIVE: STEM CELL FORECASTS Best Case Umbilical Cord Blood Banking Fees Related to Drug Development Most Likely Case Umbilical Cord Blood Banking Fees Related to Drug Development Worst Case Umbilical Cord Blood Banking Fees Related to Drug Development CHAPTER SIX: ISSUES IN STEM CELL RESEARCH Ethical Questions U.S. - State and Federal Initiatives Research Funding Federal Funding State Funding Cord Blood Initiatives International Initiatives Stem Cell Patents Other Healthcare Regulations LIST OF EXHIBITS CHAPTER ONE: EXECUTIVE SUMMARY Table 1-1 Total Market for Stem Cell Technologies in $ Millions, Table 1-2 Market in $ Millions, Table 1-3 Total Market for Cord Blood Banking Fees in $ Millions, Table 1-4 Total Market for Stem Cell Drug Development Technologies in $ Millions, Figure 1-1 Total Market for Stem Cells - Most Likely Case in $ Millions, CHAPTER TWO: INTRODUCTION Table 2-1 Established and Emerging Artificial Organ Products by Market Segment, 2010 CHAPTER THREE: CURRENT STEM CELL THERAPIES Table 3-1 Types of Leukemia, 2011 CHAPTER FOUR: DEVELOPMENTAL STEM CELL THERAPIES Table 4-1 Global Disease Populations Addressed by Potential Stem Cell Therapies, 2011 Table 4-2 Estimated and Projected World Cancer Incidence by Selected Types of Cancer, 2010 and 2020

4 Table 4-3 Estimated and Projected World Cancer Mortality by Selected Types of Cancer, 2010 and 2020 Table 4-4 Features and Types of Urinary Incontinence, 2011 Table 4-5 Types and Causes of Male Infertility, 2011 Table 4-6 Common Diseases of the Lungs, 2011 CHAPTER FIVE: STEM CELL FORECASTS Table 5-1 Persons Affected by Key Stem Cell Therapeutic Targets in Millions, 2011 Table 5-2 Best Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, Table 5-3 Best Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, Table Best Case: Cord Blood Banking Revenues in $ Millions, Table 5-5 Best Case: Stem Cell-Based Drug Development Technology Fees, Table 5-6 Best Case: Stem Cell-Based Drug Development Technology Fees in $ Millions, Table 5-7 Most Likely Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, Table 5-8 Most Likely Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, Table 5-9 Most Likely Case: Cord Blood Banking Revenues in $ Millions, Table 5-10 Most Likely Case: Stem Cell-Based Drug Development Technology Fees in Millions, Table 5-11 Most Likely Case: Stem Cell-Based Drug Development Technology Fees in $ Millions, Table 5-12 Worst Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, Table 5-13 Worst Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, Table 5-14 Worst Case: Cord Blood Banking Revenues in $ Millions, Table 5-15 Worst Case: Stem Cell-Based Drug Development Technology Fees in Millions, Table 5-16 Worst Case: Stem Cell-Based Drug Development Technology Fees in $ Millions CHAPTER SIX: ISSUES IN STEM CELL RESEARCH Table 6-1 NIH Funding for Stem Cell Research, in $ Million Table 6-2 U.S. State Embryonic & Fetal Research Laws Table 6-3 Positions on Human ES Cell Research by Country, 2011 Table 6-4 EU Laws on hesc Research by Country Ordering: Order Online - Order by Fax - using the form below Order by Post - print the order form below and send to

5 Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland.

6 Page 1 of 2 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to (from USA) or (from Rest of World). If you have any questions please visit Order Information Please verify that the product information is correct and select the format(s) you require. Product Name: Web Address: Office Code: Stem Cells: Worldwide Markets for Transplantation and Cord Blood Banking (Projections for Stem Cell Use in Cancer, Alzheimer s, Diabetes, Arthritis and Other Diseases) SC Product Formats Please select the product formats and quantity you require: Electronic (PDF) - Single User: Electronic (PDF) - Enterprisewide: Quantity USD 1995 USD 3990 Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: Last Name: Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number: * Please refrain from using free accounts when ordering (e.g. Yahoo, Hotmail, AOL)

7 Page 2 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Pay by credit card: You will receive an with a link to a secure webpage to enter your credit card details. Pay by check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Center, Taylors Lane, Dublin 8, Ireland. Pay by wire transfer: Please transfer funds to: Account number Sort code Swift code IBAN number Bank Address ULSBIE2D IE78ULSB Ulster Bank, Main Street, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at Please fax this form to: (646) or (646) From USA or From Rest of World